Global Hospital-acquired Infection Diagnostics Market Research Report 2025

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hospital-acquired Infection Diagnostics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Instrument and Reagents
1.2.3 Consumables
1.3 Market by Application
1.3.1 Global Hospital-acquired Infection Diagnostics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Ambulatory Surgery Centers (ASC)
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hospital-acquired Infection Diagnostics Market Perspective (2020-2031)
2.2 Global Hospital-acquired Infection Diagnostics Growth Trends by Region
2.2.1 Global Hospital-acquired Infection Diagnostics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Hospital-acquired Infection Diagnostics Historic Market Size by Region (2020-2025)
2.2.3 Hospital-acquired Infection Diagnostics Forecasted Market Size by Region (2026-2031)
2.3 Hospital-acquired Infection Diagnostics Market Dynamics
2.3.1 Hospital-acquired Infection Diagnostics Industry Trends
2.3.2 Hospital-acquired Infection Diagnostics Market Drivers
2.3.3 Hospital-acquired Infection Diagnostics Market Challenges
2.3.4 Hospital-acquired Infection Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hospital-acquired Infection Diagnostics Players by Revenue
3.1.1 Global Top Hospital-acquired Infection Diagnostics Players by Revenue (2020-2025)
3.1.2 Global Hospital-acquired Infection Diagnostics Revenue Market Share by Players (2020-2025)
3.2 Global Hospital-acquired Infection Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Hospital-acquired Infection Diagnostics Revenue
3.4 Global Hospital-acquired Infection Diagnostics Market Concentration Ratio
3.4.1 Global Hospital-acquired Infection Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hospital-acquired Infection Diagnostics Revenue in 2024
3.5 Global Key Players of Hospital-acquired Infection Diagnostics Head office and Area Served
3.6 Global Key Players of Hospital-acquired Infection Diagnostics, Product and Application
3.7 Global Key Players of Hospital-acquired Infection Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Hospital-acquired Infection Diagnostics Breakdown Data by Type
4.1 Global Hospital-acquired Infection Diagnostics Historic Market Size by Type (2020-2025)
4.2 Global Hospital-acquired Infection Diagnostics Forecasted Market Size by Type (2026-2031)
5 Hospital-acquired Infection Diagnostics Breakdown Data by Application
5.1 Global Hospital-acquired Infection Diagnostics Historic Market Size by Application (2020-2025)
5.2 Global Hospital-acquired Infection Diagnostics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Hospital-acquired Infection Diagnostics Market Size (2020-2031)
6.2 North America Hospital-acquired Infection Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Hospital-acquired Infection Diagnostics Market Size by Country (2020-2025)
6.4 North America Hospital-acquired Infection Diagnostics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hospital-acquired Infection Diagnostics Market Size (2020-2031)
7.2 Europe Hospital-acquired Infection Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Hospital-acquired Infection Diagnostics Market Size by Country (2020-2025)
7.4 Europe Hospital-acquired Infection Diagnostics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hospital-acquired Infection Diagnostics Market Size (2020-2031)
8.2 Asia-Pacific Hospital-acquired Infection Diagnostics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Hospital-acquired Infection Diagnostics Market Size by Region (2020-2025)
8.4 Asia-Pacific Hospital-acquired Infection Diagnostics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hospital-acquired Infection Diagnostics Market Size (2020-2031)
9.2 Latin America Hospital-acquired Infection Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Hospital-acquired Infection Diagnostics Market Size by Country (2020-2025)
9.4 Latin America Hospital-acquired Infection Diagnostics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hospital-acquired Infection Diagnostics Market Size (2020-2031)
10.2 Middle East & Africa Hospital-acquired Infection Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Hospital-acquired Infection Diagnostics Market Size by Country (2020-2025)
10.4 Middle East & Africa Hospital-acquired Infection Diagnostics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Hospital-acquired Infection Diagnostics Introduction
11.1.4 Abbott Laboratories Revenue in Hospital-acquired Infection Diagnostics Business (2020-2025)
11.1.5 Abbott Laboratories Recent Development
11.2 Advan DX
11.2.1 Advan DX Company Details
11.2.2 Advan DX Business Overview
11.2.3 Advan DX Hospital-acquired Infection Diagnostics Introduction
11.2.4 Advan DX Revenue in Hospital-acquired Infection Diagnostics Business (2020-2025)
11.2.5 Advan DX Recent Development
11.3 Abbott
11.3.1 Abbott Company Details
11.3.2 Abbott Business Overview
11.3.3 Abbott Hospital-acquired Infection Diagnostics Introduction
11.3.4 Abbott Revenue in Hospital-acquired Infection Diagnostics Business (2020-2025)
11.3.5 Abbott Recent Development
11.4 Astrazeneca PLC
11.4.1 Astrazeneca PLC Company Details
11.4.2 Astrazeneca PLC Business Overview
11.4.3 Astrazeneca PLC Hospital-acquired Infection Diagnostics Introduction
11.4.4 Astrazeneca PLC Revenue in Hospital-acquired Infection Diagnostics Business (2020-2025)
11.4.5 Astrazeneca PLC Recent Development
11.5 Bayer Schering Pharma LLC
11.5.1 Bayer Schering Pharma LLC Company Details
11.5.2 Bayer Schering Pharma LLC Business Overview
11.5.3 Bayer Schering Pharma LLC Hospital-acquired Infection Diagnostics Introduction
11.5.4 Bayer Schering Pharma LLC Revenue in Hospital-acquired Infection Diagnostics Business (2020-2025)
11.5.5 Bayer Schering Pharma LLC Recent Development
11.6 Becton Dickinson And Company
11.6.1 Becton Dickinson And Company Company Details
11.6.2 Becton Dickinson And Company Business Overview
11.6.3 Becton Dickinson And Company Hospital-acquired Infection Diagnostics Introduction
11.6.4 Becton Dickinson And Company Revenue in Hospital-acquired Infection Diagnostics Business (2020-2025)
11.6.5 Becton Dickinson And Company Recent Development
11.7 Cepheid Inc.
11.7.1 Cepheid Inc. Company Details
11.7.2 Cepheid Inc. Business Overview
11.7.3 Cepheid Inc. Hospital-acquired Infection Diagnostics Introduction
11.7.4 Cepheid Inc. Revenue in Hospital-acquired Infection Diagnostics Business (2020-2025)
11.7.5 Cepheid Inc. Recent Development
11.8 Roche AG
11.8.1 Roche AG Company Details
11.8.2 Roche AG Business Overview
11.8.3 Roche AG Hospital-acquired Infection Diagnostics Introduction
11.8.4 Roche AG Revenue in Hospital-acquired Infection Diagnostics Business (2020-2025)
11.8.5 Roche AG Recent Development
11.9 Daiichi Sankyo
11.9.1 Daiichi Sankyo Company Details
11.9.2 Daiichi Sankyo Business Overview
11.9.3 Daiichi Sankyo Hospital-acquired Infection Diagnostics Introduction
11.9.4 Daiichi Sankyo Revenue in Hospital-acquired Infection Diagnostics Business (2020-2025)
11.9.5 Daiichi Sankyo Recent Development
11.10 Hologic, Inc.
11.10.1 Hologic, Inc. Company Details
11.10.2 Hologic, Inc. Business Overview
11.10.3 Hologic, Inc. Hospital-acquired Infection Diagnostics Introduction
11.10.4 Hologic, Inc. Revenue in Hospital-acquired Infection Diagnostics Business (2020-2025)
11.10.5 Hologic, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Hospital-acquired Infection Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Instrument and Reagents
Table 3. Key Players of Consumables
Table 4. Global Hospital-acquired Infection Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Hospital-acquired Infection Diagnostics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Hospital-acquired Infection Diagnostics Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Hospital-acquired Infection Diagnostics Market Share by Region (2020-2025)
Table 8. Global Hospital-acquired Infection Diagnostics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Hospital-acquired Infection Diagnostics Market Share by Region (2026-2031)
Table 10. Hospital-acquired Infection Diagnostics Market Trends
Table 11. Hospital-acquired Infection Diagnostics Market Drivers
Table 12. Hospital-acquired Infection Diagnostics Market Challenges
Table 13. Hospital-acquired Infection Diagnostics Market Restraints
Table 14. Global Hospital-acquired Infection Diagnostics Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Hospital-acquired Infection Diagnostics Market Share by Players (2020-2025)
Table 16. Global Top Hospital-acquired Infection Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hospital-acquired Infection Diagnostics as of 2024)
Table 17. Ranking of Global Top Hospital-acquired Infection Diagnostics Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Hospital-acquired Infection Diagnostics Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Hospital-acquired Infection Diagnostics, Headquarters and Area Served
Table 20. Global Key Players of Hospital-acquired Infection Diagnostics, Product and Application
Table 21. Global Key Players of Hospital-acquired Infection Diagnostics, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Hospital-acquired Infection Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Hospital-acquired Infection Diagnostics Revenue Market Share by Type (2020-2025)
Table 25. Global Hospital-acquired Infection Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Hospital-acquired Infection Diagnostics Revenue Market Share by Type (2026-2031)
Table 27. Global Hospital-acquired Infection Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Hospital-acquired Infection Diagnostics Revenue Market Share by Application (2020-2025)
Table 29. Global Hospital-acquired Infection Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Hospital-acquired Infection Diagnostics Revenue Market Share by Application (2026-2031)
Table 31. North America Hospital-acquired Infection Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Hospital-acquired Infection Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Hospital-acquired Infection Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Hospital-acquired Infection Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Hospital-acquired Infection Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Hospital-acquired Infection Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Hospital-acquired Infection Diagnostics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Hospital-acquired Infection Diagnostics Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Hospital-acquired Infection Diagnostics Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Hospital-acquired Infection Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Hospital-acquired Infection Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Hospital-acquired Infection Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Hospital-acquired Infection Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Hospital-acquired Infection Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Hospital-acquired Infection Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 46. Abbott Laboratories Company Details
Table 47. Abbott Laboratories Business Overview
Table 48. Abbott Laboratories Hospital-acquired Infection Diagnostics Product
Table 49. Abbott Laboratories Revenue in Hospital-acquired Infection Diagnostics Business (2020-2025) & (US$ Million)
Table 50. Abbott Laboratories Recent Development
Table 51. Advan DX Company Details
Table 52. Advan DX Business Overview
Table 53. Advan DX Hospital-acquired Infection Diagnostics Product
Table 54. Advan DX Revenue in Hospital-acquired Infection Diagnostics Business (2020-2025) & (US$ Million)
Table 55. Advan DX Recent Development
Table 56. Abbott Company Details
Table 57. Abbott Business Overview
Table 58. Abbott Hospital-acquired Infection Diagnostics Product
Table 59. Abbott Revenue in Hospital-acquired Infection Diagnostics Business (2020-2025) & (US$ Million)
Table 60. Abbott Recent Development
Table 61. Astrazeneca PLC Company Details
Table 62. Astrazeneca PLC Business Overview
Table 63. Astrazeneca PLC Hospital-acquired Infection Diagnostics Product
Table 64. Astrazeneca PLC Revenue in Hospital-acquired Infection Diagnostics Business (2020-2025) & (US$ Million)
Table 65. Astrazeneca PLC Recent Development
Table 66. Bayer Schering Pharma LLC Company Details
Table 67. Bayer Schering Pharma LLC Business Overview
Table 68. Bayer Schering Pharma LLC Hospital-acquired Infection Diagnostics Product
Table 69. Bayer Schering Pharma LLC Revenue in Hospital-acquired Infection Diagnostics Business (2020-2025) & (US$ Million)
Table 70. Bayer Schering Pharma LLC Recent Development
Table 71. Becton Dickinson And Company Company Details
Table 72. Becton Dickinson And Company Business Overview
Table 73. Becton Dickinson And Company Hospital-acquired Infection Diagnostics Product
Table 74. Becton Dickinson And Company Revenue in Hospital-acquired Infection Diagnostics Business (2020-2025) & (US$ Million)
Table 75. Becton Dickinson And Company Recent Development
Table 76. Cepheid Inc. Company Details
Table 77. Cepheid Inc. Business Overview
Table 78. Cepheid Inc. Hospital-acquired Infection Diagnostics Product
Table 79. Cepheid Inc. Revenue in Hospital-acquired Infection Diagnostics Business (2020-2025) & (US$ Million)
Table 80. Cepheid Inc. Recent Development
Table 81. Roche AG Company Details
Table 82. Roche AG Business Overview
Table 83. Roche AG Hospital-acquired Infection Diagnostics Product
Table 84. Roche AG Revenue in Hospital-acquired Infection Diagnostics Business (2020-2025) & (US$ Million)
Table 85. Roche AG Recent Development
Table 86. Daiichi Sankyo Company Details
Table 87. Daiichi Sankyo Business Overview
Table 88. Daiichi Sankyo Hospital-acquired Infection Diagnostics Product
Table 89. Daiichi Sankyo Revenue in Hospital-acquired Infection Diagnostics Business (2020-2025) & (US$ Million)
Table 90. Daiichi Sankyo Recent Development
Table 91. Hologic, Inc. Company Details
Table 92. Hologic, Inc. Business Overview
Table 93. Hologic, Inc. Hospital-acquired Infection Diagnostics Product
Table 94. Hologic, Inc. Revenue in Hospital-acquired Infection Diagnostics Business (2020-2025) & (US$ Million)
Table 95. Hologic, Inc. Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
Table 99. Authors List of This Report


List of Figures
Figure 1. Hospital-acquired Infection Diagnostics Picture
Figure 2. Global Hospital-acquired Infection Diagnostics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Hospital-acquired Infection Diagnostics Market Share by Type: 2024 VS 2031
Figure 4. Instrument and Reagents Features
Figure 5. Consumables Features
Figure 6. Global Hospital-acquired Infection Diagnostics Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Hospital-acquired Infection Diagnostics Market Share by Application: 2024 VS 2031
Figure 8. Hospital Case Studies
Figure 9. Clinics Case Studies
Figure 10. Ambulatory Surgery Centers (ASC) Case Studies
Figure 11. Others Case Studies
Figure 12. Hospital-acquired Infection Diagnostics Report Years Considered
Figure 13. Global Hospital-acquired Infection Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Hospital-acquired Infection Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Hospital-acquired Infection Diagnostics Market Share by Region: 2024 VS 2031
Figure 16. Global Hospital-acquired Infection Diagnostics Market Share by Players in 2024
Figure 17. Global Top Hospital-acquired Infection Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hospital-acquired Infection Diagnostics as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Hospital-acquired Infection Diagnostics Revenue in 2024
Figure 19. North America Hospital-acquired Infection Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Hospital-acquired Infection Diagnostics Market Share by Country (2020-2031)
Figure 21. United States Hospital-acquired Infection Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Hospital-acquired Infection Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Hospital-acquired Infection Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Hospital-acquired Infection Diagnostics Market Share by Country (2020-2031)
Figure 25. Germany Hospital-acquired Infection Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Hospital-acquired Infection Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Hospital-acquired Infection Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Hospital-acquired Infection Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Hospital-acquired Infection Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Hospital-acquired Infection Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Hospital-acquired Infection Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Hospital-acquired Infection Diagnostics Market Share by Region (2020-2031)
Figure 33. China Hospital-acquired Infection Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Hospital-acquired Infection Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Hospital-acquired Infection Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Hospital-acquired Infection Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Hospital-acquired Infection Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Hospital-acquired Infection Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Hospital-acquired Infection Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Hospital-acquired Infection Diagnostics Market Share by Country (2020-2031)
Figure 41. Mexico Hospital-acquired Infection Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Hospital-acquired Infection Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Hospital-acquired Infection Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Hospital-acquired Infection Diagnostics Market Share by Country (2020-2031)
Figure 45. Turkey Hospital-acquired Infection Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Hospital-acquired Infection Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Hospital-acquired Infection Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Abbott Laboratories Revenue Growth Rate in Hospital-acquired Infection Diagnostics Business (2020-2025)
Figure 49. Advan DX Revenue Growth Rate in Hospital-acquired Infection Diagnostics Business (2020-2025)
Figure 50. Abbott Revenue Growth Rate in Hospital-acquired Infection Diagnostics Business (2020-2025)
Figure 51. Astrazeneca PLC Revenue Growth Rate in Hospital-acquired Infection Diagnostics Business (2020-2025)
Figure 52. Bayer Schering Pharma LLC Revenue Growth Rate in Hospital-acquired Infection Diagnostics Business (2020-2025)
Figure 53. Becton Dickinson And Company Revenue Growth Rate in Hospital-acquired Infection Diagnostics Business (2020-2025)
Figure 54. Cepheid Inc. Revenue Growth Rate in Hospital-acquired Infection Diagnostics Business (2020-2025)
Figure 55. Roche AG Revenue Growth Rate in Hospital-acquired Infection Diagnostics Business (2020-2025)
Figure 56. Daiichi Sankyo Revenue Growth Rate in Hospital-acquired Infection Diagnostics Business (2020-2025)
Figure 57. Hologic, Inc. Revenue Growth Rate in Hospital-acquired Infection Diagnostics Business (2020-2025)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed

Your Name

Your E-mail

Your message

Submit